Skip to main navigation Skip to search Skip to main content

Validation of multiple linked administrative datasets to identify people with dementia

  • Thao Vu (Leading Author)
  • , Osvaldo P. Almeida
  • , Leon Flicker
  • , Michael Waller
  • , Rory Wolfe
  • , Joanne Ryan
  • , Robyn L. Woods
  • , Michelle Wilson
  • , Annette J. Dobson

Research output: Contribution to journal › Article › Research › peer-review

Abstract

Background: Accurately measuring dementia prevalence and incidence (including Alzheimer's disease) is important for service planning and chronic condition management. Linked administrative data present an accessible and inexpensive method to estimate dementia prevalence and incidence. Objective: To examine the accuracy of identifying people with dementia in linked administrative data through comparison with adjudicated cases of dementia from a community-based clinical trial. Methods: We created a comprehensive linked administrative dataset containing people with dementia in Australia and used it to develop algorithms that identified people with dementia. These algorithms were tested against adjudicated cases of dementia (both confirmed and not confirmed) in the ASPirin in Reducing Events in the Elderly (ASPREE) clinical trial (Number: ISRCTN83772183, Registration date: 14/07/2005) to help determine optimal sensitivity and specificity. Results: The algorithm that provided the highest sensitivity and positive predictive value estimates on balance without excluding ASPREE trial participants with suspected (but not confirmed) dementia was having at least one record for dementia in a minimum of two sources or two records with dementia in one source based on truncating the timeframe of randomization in the ASPREE trial to one year from the date that the first participant was randomized. This algorithm produced a sensitivity of 70.7%, specificity of 98.2%, positive predictive value of 72.6% and negative predictive value of 98.1%. Conclusions: Linked administrative data can identify people with dementia with moderate accuracy. This is promising but requires enhancement before it can be used for estimating dementia prevalence and incidence. Clinical trial name and URL: ASPirin in Reducing Events in the Elderly; ISRCTN - ISRCTN83772183: ASPirin in Reducing Events in the Elderly (https://www.isrctn.com/ISRCTN83772183).

Original languageEnglish
Pages (from-to)671-681
Number of pages11
JournalJournal of Alzheimer's Disease
Volume107
Issue number2
DOIs
Publication statusPublished - Sept 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • administrative data
  • Alzheimer's disease
  • dementia
  • incidence
  • linked data
  • prevalence
  • validation

Cite this